Page last updated: 2024-09-03

ono 3307 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ono 3307 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(ono 3307)
Trials
(ono 3307)
Recent Studies (post-2010)
(ono 3307)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
12019,156187552

Protein Interaction Comparison

ProteinTaxonomyono 3307 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aosasa, S; Kinoshita, M; Mochizuki, H; Oda, Y; Ohe, H; Ohkusa, Y; Ono, S; Tamakuma, S1

Other Studies

1 other study(ies) available for ono 3307 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
    Surgery today, 1993, Volume: 23, Issue:3

    Topics: Aged; Animals; Blood Pressure; Disseminated Intravascular Coagulation; Female; Fibrinolysis; Guanidines; Humans; Male; Middle Aged; Neoplasms; Platelet Activating Factor; Platelet Count; Postoperative Complications; Rabbits; Serine Proteinase Inhibitors; Shock, Septic; Thiazoles; Thiazolidines

1993